Indiva (NDVAF, $0.02) lost over the last three months. By comparison, the broader Pharmaceuticals: Other Industry returned over the same period. A.I.dvisor analyzed 275 stocks in the Pharmaceuticals: Other Industry over the last three months, and found that of them (4) exhibited an Uptrend while of them (5) experienced a Downtrend.